ResMed Stock Rises Above $240 on Earnings Beat and Dividend Hike

ResMed stock rose above $240 after its latest quarterly earnings report showed revenue and profit exceeding expectations. The medical equipment and cloud-connected health company reported a net margin of 26.94 percent, indicating that more than one quarter of every dollar of revenue fell to the bottom line after all expenses.

The company's recent dividend increase to $0.66 per share reflects ongoing confidence in cash generation, with an annualized payout of $2.64 per share and a forward dividend yield of approximately 1.1 percent. Analysts expect steady performance over the remaining quarters, with some room for seasonal variation.

ResMed's shares have been trading at around $240, close to the average analyst price target of $239.38. The company's market capitalization is in the tens of billions of US dollars, and it holds a significant portion of its equity through institutional investors.